Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$8.23B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 3 |
NVIDIA
NVDA
|
+$1.45B |
| 4 |
T-Mobile US
TMUS
|
+$1.41B |
| 5 |
Broadcom
AVGO
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.04B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.7B |
| 3 |
Amazon
AMZN
|
+$2.11B |
| 4 |
Microsoft
MSFT
|
+$2.02B |
| 5 |
Merck
MRK
|
+$1.79B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.15% |
| 2 | Healthcare | 19.44% |
| 3 | Financials | 13.51% |
| 4 | Consumer Discretionary | 9.13% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Kyndryl
KD
$3.07B
| $867K | ﹤0.01% |
32,958
+20,688
| +169% | +$496K |
|
1602
Design Therapeutics
DSGN
$849M
| $860K | ﹤0.01% |
256,627
+42,317
| +20% | +$165K |
|
1603
Strategy Inc
MSTR
$35.9B
| $858K | ﹤0.01% |
6,230
-200,920
| -97% | -$29M |
|
1604
Caribou Biosciences
CRBU
$160M
| $858K | ﹤0.01% |
523,250
+81,444
| +18% | +$260K |
|
|
ANSS
1605
DELISTED
Ansys
ANSS
| $852K | ﹤0.01% |
2,649
+169
| +7% | +$55.4K |
|
1606
Black Diamond Therapeutics
BDTX
$103M
| $847K | ﹤0.01% |
181,675
+15,989
| +10% | +$85.8K |
|
1607
Atea Pharmaceuticals
AVIR
$380M
| $845K | ﹤0.01% |
255,166
-94,838
| -27% | -$354K |
|
1608
Western Union
WU
$2.26B
| $832K | ﹤0.01% |
68,091
-28,885
| -30% | -$375K |
|
1609
Viatris
VTRS
$20.6B
| $824K | ﹤0.01% |
77,500
+5,022
| +7% | +$55.5K |
|
1610
Futu Holdings
FUTU
$15.5B
| $813K | ﹤0.01% |
12,390
+7,544
| +156% | +$510K |
|
1611
Ameriprise Financial
AMP
$49.6B
| $811K | ﹤0.01% |
1,898
-5,065
| -73% | -$2.16M |
|
1612
Dropbox
DBX
$8.17B
| $809K | ﹤0.01% |
+35,994
| New | +$823K |
|
|
ESPR
1613
DELISTED
Esperion Therapeutics
ESPR
| $802K | ﹤0.01% |
361,424
+597
| +0.2% | +$1.4K |
|
1614
Robinhood
HOOD
$83.4B
| $801K | ﹤0.01% |
35,257
-935,475
| -96% | -$18.3M |
|
|
WBA
1615
DELISTED
Walgreens Boots Alliance
WBA
| $798K | ﹤0.01% |
65,968
-10,339
| -14% | -$175K |
|
1616
Enliven Therapeutics
ELVN
$4.26B
| $792K | ﹤0.01% |
+33,903
| New | +$714K |
|
1617
EPR Properties
EPR
$4.68B
| $792K | ﹤0.01% |
18,871
-12,348
| -40% | -$508K |
|
1618
Gildan
GIL
$10.8B
| $791K | ﹤0.01% |
20,869
+1,765
| +9% | +$63.8K |
|
1619
Check Point Software Technologies
CHKP
$12.8B
| $791K | ﹤0.01% |
4,792
+873
| +22% | +$136K |
|
1620
Harmony Biosciences
HRMY
$2.21B
| $788K | ﹤0.01% |
26,127
+1,726
| +7% | +$51.9K |
|
1621
Erie Indemnity
ERIE
$13.1B
| $784K | ﹤0.01% |
2,163
+122
| +6% | +$46.4K |
|
1622
Cummins
CMI
$89.7B
| $783K | ﹤0.01% |
2,827
-525
| -16% | -$150K |
|
1623
Emergent Biosolutions
EBS
$389M
| $777K | ﹤0.01% |
+113,994
| New | +$491K |
|
1624
Boston Properties
BXP
$11.2B
| $760K | ﹤0.01% |
12,338
+1,361
| +12% | +$83.2K |
|
1625
Southwest Airlines
LUV
$23.9B
| $758K | ﹤0.01% |
26,486
-10,369,235
| -100% | -$289M |
|
Similar funds
Wellington Management Group's Q2 2024 Portfolio in Review
As of Q2 2024, Wellington Management Group held 2,006 positions worth $560B, down 0.75% from $564B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Wellington Management Group's Q2 2024 filing shows 120 new, 834 increased, 756 reduced and 132 closed positions. Its largest new stake was Pool Corp: 1,100,398 shares worth $338M. The largest sale was Meta Platforms (Facebook), an estimated $3.04B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Wellington Management Group's largest Q2 2024 buy was Pool Corp: 1,100,398 shares worth $338M.
- Wellington Management Group added most to Apple in Q2 2024, an estimated $8.23B increase.
- Wellington Management Group's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $3.04B.
- Wellington Management Group fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $850M.
- Wellington Management Group's ten largest holdings make up 24% of its $560B portfolio in Q2 2024.
- Wellington Management Group opened 120 new positions and closed 132 in Q2 2024.
- Wellington Management Group's portfolio value fell 0.75% quarter-over-quarter to $560B.
Based on Wellington Management Group's 13F filing for Q2 2024, filed 14 Aug 2024.